Patients with a rare neurodegenerative brain disorder called Primary Progressive Aphasia, or PPA, show abnormalities in brain function in areas that look structurally normal on
In a records review of 290 people at risk for Alzheimer’s disease, scientists say they have identified an average level of biological and anatomical brain
The Alzheimer drug candidate PRI-002 has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks,
In a group of former professional athletes who experienced multiple concussions, a new study has found that approximately half the group had higher than normal
A new study has found that a particular class of molecules may help with diagnosing Alzheimer’s Disease.